126 related articles for article (PubMed ID: 18811590)
1. Autoactivation of human ADAM8: a novel pre-processing step is required for catalytic activity.
Hall T; Leone JW; Wiese JF; Griggs DW; Pegg LE; Pauley AM; Tomasselli AG; Zack MD
Biosci Rep; 2009 Aug; 29(4):217-28. PubMed ID: 18811590
[TBL] [Abstract][Full Text] [Related]
2. ADAM8 substrate specificity: influence of pH on pre-processing and proteoglycan degradation.
Hall T; Pegg LE; Pauley AM; Fischer HD; Tomasselli AG; Zack MD
Arch Biochem Biophys; 2009 Nov; 491(1-2):106-11. PubMed ID: 19766586
[TBL] [Abstract][Full Text] [Related]
3. Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors.
Sriraman V; Eichenlaub-Ritter U; Bartsch JW; Rittger A; Mulders SM; Richards JS
Biol Reprod; 2008 Jun; 78(6):1038-48. PubMed ID: 18287572
[TBL] [Abstract][Full Text] [Related]
4. Catalytic properties of ADAM12 and its domain deletion mutants.
Jacobsen J; Visse R; Sørensen HP; Enghild JJ; Brew K; Wewer UM; Nagase H
Biochemistry; 2008 Jan; 47(2):537-47. PubMed ID: 18081311
[TBL] [Abstract][Full Text] [Related]
5. ADAM19 autolysis is activated by LPS and promotes non-classical secretion of cysteine-rich protein 2.
Tanabe C; Hotoda N; Sasagawa N; Futai E; Komano H; Ishiura S
Biochem Biophys Res Commun; 2010 Jun; 396(4):927-32. PubMed ID: 20460109
[TBL] [Abstract][Full Text] [Related]
6. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness.
Wildeboer D; Naus S; Amy Sang QX; Bartsch JW; Pagenstecher A
J Neuropathol Exp Neurol; 2006 May; 65(5):516-27. PubMed ID: 16772875
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification and insights into structure and folding of the ADAM22 pro domain.
Sørensen HP; Jacobsen J; Nielbo S; Poulsen FM; Wewer UM
Protein Expr Purif; 2008 Oct; 61(2):175-83. PubMed ID: 18593599
[TBL] [Abstract][Full Text] [Related]
8. ADAMs and protein disulfide isomerase: the key to regulated cell-surface protein ectodomain shedding?
Bass R; Edwards DR
Biochem J; 2010 May; 428(3):e3-5. PubMed ID: 20504280
[TBL] [Abstract][Full Text] [Related]
9. The Functional Maturation of A Disintegrin and Metalloproteinase (ADAM) 9, 10, and 17 Requires Processing at a Newly Identified Proprotein Convertase (PC) Cleavage Site.
Wong E; Maretzky T; Peleg Y; Blobel CP; Sagi I
J Biol Chem; 2015 May; 290(19):12135-46. PubMed ID: 25795784
[TBL] [Abstract][Full Text] [Related]
10. Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin.
Schwettmann L; Tschesche H
Protein Expr Purif; 2001 Feb; 21(1):65-70. PubMed ID: 11162388
[TBL] [Abstract][Full Text] [Related]
11. Role of ADAM8 in experimental asthma.
Matsuno O; Miyazaki E; Nureki S; Ueno T; Kumamoto T; Higuchi Y
Immunol Lett; 2006 Jan; 102(1):67-73. PubMed ID: 16154205
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.
Naus S; Reipschläger S; Wildeboer D; Lichtenthaler SF; Mitterreiter S; Guan Z; Moss ML; Bartsch JW
Biol Chem; 2006 Mar; 387(3):337-46. PubMed ID: 16542157
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory antibodies against endopeptidase activity of human adamalysin 19.
Zhao YG; Wei P; Sang QX
Biochem Biophys Res Commun; 2001 Nov; 289(1):288-94. PubMed ID: 11708814
[TBL] [Abstract][Full Text] [Related]
14. The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion.
Schlomann U; Wildeboer D; Webster A; Antropova O; Zeuschner D; Knight CG; Docherty AJ; Lambert M; Skelton L; Jockusch H; Bartsch JW
J Biol Chem; 2002 Dec; 277(50):48210-9. PubMed ID: 12372841
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of the autolysis of AaHIV suggests a novel target recognizing model for ADAM/reprolysin family proteins.
Zhu Z; Gao Y; Zhu Z; Yu Y; Zhang X; Zang J; Teng M; Niu L
Biochem Biophys Res Commun; 2009 Aug; 386(1):159-64. PubMed ID: 19505434
[TBL] [Abstract][Full Text] [Related]
16. The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies.
Dehmel T; Janke A; Hartung HP; Goebel HH; Wiendl H; Kieseier BC
Neurobiol Dis; 2007 Mar; 25(3):665-74. PubMed ID: 17207628
[TBL] [Abstract][Full Text] [Related]
17. Involvement of a disintegrin and a metalloproteinase 8 (ADAM8) in osteoclastogenesis and pathological bone destruction.
Ainola M; Li TF; Mandelin J; Hukkanen M; Choi SJ; Salo J; Konttinen YT
Ann Rheum Dis; 2009 Mar; 68(3):427-34. PubMed ID: 18397961
[TBL] [Abstract][Full Text] [Related]
18. The TACE zymogen: re-examining the role of the cysteine switch.
Milla ME; Gonzales PE; Leonard JD
Cell Biochem Biophys; 2006; 44(3):342-8. PubMed ID: 16679521
[TBL] [Abstract][Full Text] [Related]
19. ADAM8 in asthma. Friend or foe to airway inflammation?
Chen J; Jiang X; Duan Y; Long J; Bartsch JW; Deng L
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):875-84. PubMed ID: 23837412
[TBL] [Abstract][Full Text] [Related]
20. ADAM8 in allergy.
Matsuno O; Kumamoto T; Higuchi Y
Inflamm Allergy Drug Targets; 2008 Jun; 7(2):108-12. PubMed ID: 18691140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
